Full history for every metric is available with a Kvantra account
Key financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | SGD m | - | - | - | - | - | - | - |
| Operating profit | SGD m | - | ||||||
| Net profit | SGD m | - | - | - | - | - | - | - |
| EPS reported | SGD | - | ||||||
| Operating cashflow per share | SGD | - | ||||||
| Capex per share | SGD | - | ||||||
| FCF per share | SGD | - | ||||||
| Free cash flow | SGD m | - | ||||||
| Net debt | SGD m | - | ||||||
| Book value equity | SGD m | - | ||||||
| Book value per share | SGD | - | ||||||
| Number of shares | m | - | ||||||
| DPS (TTM paid) | SGD | - |
Financial summary
Financials in SGDTTM unavailable because four recent quarterly reports are not available| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | ||||||
| P/B LTM | x | - | ||||||
| P/S LTM | x | - | ||||||
| P/FCF LTM | x | - | ||||||
| EV/EBITDA LTM | x | - | ||||||
| EV/Sales LTM | x | - | ||||||
| Earnings Yield LTM | % | - | ||||||
| FCF Yield | % | - | ||||||
| Quality | ||||||||
| ROE | % | - | ||||||
| ROIC | % | - | ||||||
| Operating margin | % | - | ||||||
| Gross margin | % | - | ||||||
| FCF/Sales | % | - | ||||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | ||||||
| Sales Growth YoY | % | - | ||||||
| Net Income Growth YoY | % | - | ||||||
| FCF Growth | % | - | ||||||
| Operating Profit Growth | % | - | ||||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | - | ||||||
| Dividend Growth | % | - | ||||||
| Payout Ratio | % | - | ||||||
| FCF/Debt | x | - | ||||||
| Net Debt/EBITDA | x | - | ||||||
| EBIT/Net interest | x | - | ||||||
| Net debt/market cap | % | - | ||||||
| Net debt/Equity | x | - | ||||||
| Gross debt/equity | x | - | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
UpHealth Group Limited operates in the medical business in Russia. The company offers cancer diagnostics and treatment, and antitumor and palliative treatment services through oncology clinics under the Euroonco brand. The company was formerly known as Don Agro International Limited and changed its name to UpHealth Group Limited in January 2026. The company was incorporated in 2018 and is based in Singapore.
Similar companies
- Vaidya Sane Ayurved Laboratories Ltd.
- International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company
- D & M Company Co., Ltd.
- Care Service Co.,Ltd.
- Emergency Assistance Japan Co., Ltd.
- Balsm Alofoq Medical Co.
- China Evergrande New Energy Vehicle Group Limited
- CEDAR.Co.,Ltd.
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Not enough data to calculate KvantraRank
Based on consensus from external analysts. Not Kvantra's opinion.
UpHealth Group Limited operates in the medical business in Russia. The company offers cancer diagnostics and treatment, and antitumor and palliative treatment services through oncology clinics under the Euroonco brand. The company was formerly known as Don Agro International Limited and changed its name to UpHealth Group Limited in January 2026. The company was incorporated in 2018 and is based in Singapore.
- Vaidya Sane Ayurved Laboratories Ltd.
- International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company
- D & M Company Co., Ltd.
- Care Service Co.,Ltd.
- Emergency Assistance Japan Co., Ltd.
- Balsm Alofoq Medical Co.
- China Evergrande New Energy Vehicle Group Limited
- CEDAR.Co.,Ltd.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free